Vip (10mg)
VIP (Vasoactive Intestinal Peptide) is a naturally occurring neuropeptide composed of 28 amino acids. It is widely studied in molecular biology, neuroendocrine signaling, and immune-system research due to its role in cellular communication and receptor-mediated signaling pathways.
VIP interacts with specific G-protein–coupled receptors (VPAC1 and VPAC2), which are distributed throughout the nervous system, gastrointestinal tract, and immune tissues. Because of these interactions, VIP is frequently examined in studies involving neurotransmission, inflammatory signaling, and smooth muscle regulation.
GENIQ supplies VIP strictly for laboratory research only—not for human or animal use.
$199.99
-
Official retailer
-
Quality guaranteed
-
Free delivery from $99
-
Free returns is available
What Is VIP?
VIP (Vasoactive Intestinal Peptide) is a naturally occurring neuropeptide composed of 28 amino acids. It is widely studied in molecular biology, neuroendocrine signaling, and immune-system research due to its role in cellular communication and receptor-mediated signaling pathways.
VIP interacts with specific G-protein–coupled receptors (VPAC1 and VPAC2), which are distributed throughout the nervous system, gastrointestinal tract, and immune tissues. Because of these interactions, VIP is frequently examined in studies involving neurotransmission, inflammatory signaling, and smooth muscle regulation.
GENIQ supplies VIP strictly for laboratory research only—not for human or animal use.
Peptide Overview
VIP is an important signaling peptide involved in numerous physiological communication pathways.
In controlled laboratory environments, researchers examine how VIP may promote changes in:
| Neurotransmitter signaling and neuronal communication |
| Smooth muscle relaxation pathways |
| Immune-system signaling and cytokine regulation |
| Gastrointestinal neuroendocrine activity |
| Vasodilation-related biochemical mechanisms |
| Cellular communication through GPCR receptor systems |
| Inflammatory and anti-inflammatory signaling pathways |
| All findings originate exclusively from experimental research environments. |
All findings remain limited to preclinical and in-vitro experimental environments.
History of VIP
Vasoactive Intestinal Peptide was first isolated in the early 1970s from intestinal tissue during research investigating gastrointestinal hormone regulation.
Scientists later discovered that VIP is widely distributed throughout the nervous system and functions as both a neurotransmitter and neuromodulator.
| Over time, VIP became an important subject in studies involving: |
| • Neuroendocrine signaling |
| • Gastrointestinal physiology |
| • Immune modulation pathways |
| • Vascular smooth-muscle regulation |
| • Circadian and neurological signaling systems |
| • Cellular receptor communication |
| Its broad biological distribution has made VIP a widely studied peptide in neuroscience, immunology, and physiology research. |
Peptide Structure
Sequence: HSDAVFTDNYTRLRKQMAVKKYLNSILN
Certificates of Analysis
VIP — 10mg
Research Findings
Research involving VIP commonly focuses on:
| Neurotransmitter signaling: Studies examine VIP’s role in neuronal communication and neuromodulation. |
| Immune-system pathways: Researchers analyze cytokine regulation and immune-cell signaling influenced by VIP. |
| Smooth muscle regulation: Laboratory models investigate biochemical pathways associated with smooth-muscle relaxation. |
| Vascular signaling: Studies explore VIP’s involvement in vasodilation-related mechanisms. |
| Gastrointestinal research: VIP is studied in relation to gut–brain signaling and neuroendocrine regulation. |
| Receptor-mediated pathways: Research examines VIP interaction with VPAC receptors and downstream signaling effects. |
| These findings are limited to laboratory research environments and do not represent clinical outcomes. |
These findings reflect laboratory experiments only and do not indicate clinical outcomes.
References
2. Neuroendocrine Research Institute. “VIP signaling and receptor-mediated pathways.”
3. Immunology Signaling Laboratory. “Neuropeptide involvement in immune-cell communication.”
4. Gastrointestinal Physiology Group. “Vasoactive peptides and smooth muscle regulation.”
FAQ
What type of research is VIP used for?
VIP is commonly studied in research involving neuroendocrine signaling, immune regulation, vascular biology, and gastrointestinal physiology.
Does GENIQ provide a Certificate of Analysis?
Yes. Every GENIQ compound includes a COA verifying identity and purity.
Is VIP approved for human or veterinary use?
No. VIP is not FDA-approved and is not intended for human or animal administration.
Does GENIQ provide preparation or dosing instructions?
No. GENIQ does not provide any preparation or usage guidance.
Who should handle this compound?
Only trained researchers operating within controlled laboratory environments.
Research Use Only
All GENIQ compounds are intended strictly for laboratory research.
Not for human or animal consumption, medical use, or therapeutic application.
Nothing in this document should be interpreted as medical advice or as approval for use outside controlled scientific environments.
VIP (Vasoactive Intestinal Peptide) is a naturally occurring neuropeptide composed of 28 amino acids. It is widely studied in molecular biology, neuroendocrine signaling, and immune-system research due to its role in cellular communication and receptor-mediated signaling pathways.
VIP interacts with specific G-protein–coupled receptors (VPAC1 and VPAC2), which are distributed throughout the nervous system, gastrointestinal tract, and immune tissues. Because of these interactions, VIP is frequently examined in studies involving neurotransmission, inflammatory signaling, and smooth muscle regulation.
GENIQ supplies VIP strictly for laboratory research only—not for human or animal use.
RELATED PRODUCTS
